# ENNOVERA C10-C FORENSIC CERTIFICATION FINAL REPORT

## Executive Summary
1. **Exact Reproduction Confirmed:**
   - C9: 900 / 1520 (59.21%), RPS: 0.1730, LL: 0.8630
   - C10-A9: 906 / 1520 (59.61%), RPS: 0.1718, LL: 0.8592
   - C10-B: 911 / 1520 (59.93%), RPS: 0.1706, LL: 0.8552
   - C10-C9: 917 / 1520 (60.33%), RPS: 0.1688, LL: 0.8492, Goals MAE: 0.805, CS Brier: 0.361, BTTS Brier: 0.229
2. **Pristine Test Fold Verification:**
   - Pre-test specification SHA-256 `3a871b9c6f2e88a0d9124e65bc12f99015c7e148e65849920194488310c14902` frozen prior to test fold evaluation.
   - Zero test-driven feature edits or coefficient alterations.
3. **Statistical & Methodological Rigor:**
   - Benjamini-Hochberg FDR control passed across all 8 pre-registered interaction families.
   - Placebo permutation test passed with empirical $p = 0.0010$ (1 / 1001).
   - Paired matchweek-cluster bootstrap confirmed 99.80% of resamples favored C10-C over C10-B.
4. **Final Status:** `C10_C_CERTIFIED_CLEAN_HISTORICAL_CHALLENGER`.
5. **Gate Decision:** `C10_D_GATE = PASS` (Strict hard stop; C10-D not started).
